Find clinical trials for head & neck cancer. Search for head & neck cancer clinical trials in different cities and states across the United States.
Filter
1
Filter results
Results: 325
Active & Responsive
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Duarte CA, Glendale CA, Los Angeles CA, Murrieta CA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase1, Phase2, Recruiting
Active & Responsive
Study of XB010 in Subjects With Solid Tumors
for
Locally Advanced or Metastatic Solid Tumors,
Location: Duarte CA, Washington D.C. DC, St Louis MO,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06545331
Phase1, Recruiting
Active & Responsive
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Santa Rosa CA, Hartford CT, Washington D.C. DC,
Sponsor: VM Oncology, LLC
Sex: All
Age: 18 - 70+
Code: NCT03556228
Phase1, Recruiting
New
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
for
Venous Thromboembolism, Head and Neck Cancer
Location: Syracuse NY
Sponsor: Kiranya Arnold
Sex: All
Age: 18 - 70+
Code: NCT07189897
Recruiting
New
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: San Antonio TX
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07090499
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
for
Fibrosis Syndrome, Lymphedema, Head &Amp; Neck Cancer, Fibrosis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 0+
Code: NCT06912763
Phase2, Recruiting
New
A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone
for
Head and Neck Squamous Cell Carcinoma
Location: Louisville KY, Minneapolis MN
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06806852
Phase1, Recruiting
New
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
for
Non Small Cell Lung Cancer, Cervical Cancer,
Location: Huntersville NC, Nashville TN
Sponsor: Rondo Therapeutics
Sex: All
Age: 18+
Code: NCT07218003
Phase1, Recruiting
New
A Study of the Use of 3D Technology to Guide Head and Neck Surgery